Cancer Research PRL Inhibitor Induces the Cleavage of p130Cas  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 47, 4869-4876, September 15, 1987]
© 1987 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakajima, M.
Right arrow Articles by Nicolson, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakajima, M.
Right arrow Articles by Nicolson, G. L.

Degradation of Basement Membrane Type IV Collagen and Lung Subendothelial Matrix by Rat Mammary Adenocarcinoma Cell Clones of Differing Metastatic Potentials1

Motowo Nakajima, Danny R. Welch2, Paula N. Belloni and Garth L. Nicolson3

Department of Tumor Biology, The University of Texas M. D. Anderson Hospital and Tumor Institute, Houston, Texas 77030

A series of rat 13762NF mammary adenocarcinoma cell clones and subclones of various lung metastatic potentials were examined for their abilities to degrade rat lung subendothelial matrix and purified basement membrane type IV collagen. Metastatic potentials were simultaneously determined based on the ability to form "spontaneous" lung metastases after s.c. injection or "experimental" lung metastases after i.v. injection of cells. Microvessel endothelial cells isolated from rat lung were grown in vitro, and the subendothelial matrix containing type IV collagen was metabolically labeled with [3H]proline. When mammary adenocarcinoma cells were placed on the isolated subendothelial matrix, fragmentation and solubilization of [3H]proline-labeled components were observed; highly metastatic 13762NF cells solubilized the matrix at higher rates than did poorly metastatic cells. The 13762NF cells were assayed for type IV collagenolytic activity using [3H]proline-labeled type IV collagen purified from Engelbreth-Holm-Swarm tumor as a substrate. We found excellent correlation between the type IV collagenolytic activities of living cells and their "spontaneous" lung metastatic potentials (r = 0.993). The levels of type IV collagenolytic activity in the conditioned medium depended on the cell culture conditions. In the presence or absence of acidtreated fetal bovine serum, highly metastatic cells secreted higher amounts of type IV collagenolytic enzymes in active and latent forms than did poorly metastatic cells. Incubation of procollagen type IV with medium conditioned by highly metastatic 13762NF cells and treated with trypsin resulted in the production of several large fragments characteristic of type IV collagen. The results suggest that enzymatic degradation of basement membrane type IV collagen is important in lung metastasis of 13762NF mammary adenocarcinoma cells.

1 Supported by USPHS National Cancer Institute Grant RO1-CA28844 and R35-CA44352 (O.I.A.) to G. L. N. and RO1-CA41524 to M. N.

2 Present address: Cancer Research, The Upjohn Company, Kalamazoo, MI 49001.

3 To whom requests for reprints should be addressed, at the Department of Tumor Biology, The University of Texas M. D. Anderson Hospital and Tumor Institute, Houston, TX 77030.

Received 3/24/86. Revised 6/16/87. Accepted 6/23/87.




This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
J.-i. Hamada, D. Nakata, D. Nakae, Y. Kobayashi, H. Akai, Y. Konishi, F. Okada, T. Shibata, M. Hosokawa, and T. Moriuchi
Increased Oxidative DNA Damage in Mammary Tumor Cells by Continuous Epidermal Growth Factor Stimulation
J Natl Cancer Inst, February 7, 2001; 93(3): 214 - 219.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. B. Wyckoff, J. E. Segall, and J. S. Condeelis
The Collection of the Motile Population of Cells from a Living Tumor
Cancer Res., October 1, 2000; 60(19): 5401 - 5404.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
M. Määttä, Y. Soini, A. Liakka, and H. Autio-Harmainen
Differential Expression of Matrix Metalloproteinase (MMP)-2, MMP-9, and Membrane Type 1-MMP in Hepatocellular and Pancreatic Adenocarcinoma: Implications for Tumor Progression and Clinical Prognosis
Clin. Cancer Res., July 1, 2000; 6(7): 2726 - 2734.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
M. Hanzawa, M. Shindoh, F. Higashino, M. Yasuda, N. Inoue, K. Hida, M. Ono, T. Kohgo, M. Nakamura, K.-i. Notani, et al.
Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes
Carcinogenesis, June 1, 2000; 21(6): 1079 - 1085.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Koochekpour, M. Jeffers, P. H. Wang, C. Gong, G. A. Taylor, L. M. Roessler, R. Stearman, J. R. Vasselli, W. G. Stetler-Stevenson, W. G. Kaelin Jr., et al.
The von Hippel-Lindau Tumor Suppressor Gene Inhibits Hepatocyte Growth Factor/Scatter Factor-Induced Invasion and Branching Morphogenesis in Renal Carcinoma Cells
Mol. Cell. Biol., September 1, 1999; 19(9): 5902 - 5912.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. Takeshita, T. Yoshizaki, W. E. Miller, H. Sato, M. Furukawa, J. S. Pagano, and N. Raab-Traub
Matrix Metalloproteinase 9 Expression Is Induced by Epstein-Barr Virus Latent Membrane Protein 1 C-Terminal Activation Regions 1 and 2
J. Virol., July 1, 1999; 73(7): 5548 - 5555.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
Z.-S. Zeng, A. M. Cohen, and J. G. Guillem
Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis
Carcinogenesis, May 1, 1999; 20(5): 749 - 755.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Iizasa, T. Fujisawa, M. Suzuki, S.-i. Motohashi, K. Yasufuku, T. Yasukawa, M. Baba, and M. Shiba
Elevated Levels of Circulating Plasma Matrix Metalloproteinase 9 in Non-Small Cell Lung Cancer Patients
Clin. Cancer Res., January 1, 1999; 5(1): 149 - 153.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Yoshizaki, H. Sato, M. Furukawa, and J. S. Pagano
The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1
PNAS, March 31, 1998; 95(7): 3621 - 3626.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. H. Bu and T. Pourmotabbed
Mechanism of Ca2+-dependent Activity of Human Neutrophil Gelatinase B
J. Biol. Chem., June 14, 1996; 271(24): 14308 - 14315.
[Abstract] [Full Text] [PDF]


Home page
CROBMHome page
H. Birkedal-Hansen, W.G.I. Moore, M.K. Bodden, L.J. Windsor, B. Birkedal-Hansen, A. DeCarlo, and J.A. Engler
Matrix Metalloproteinases: A Review
Critical Reviews in Oral Biology & Medicine, January 1, 1993; 4(2): 197 - 250.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
R Khokha, P Waterhouse, S Yagel, P. Lala, C. Overall, G Norton, and D. Denhardt
Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells
Science, February 17, 1989; 243(4893): 947 - 950.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
U. T. Shankavaram, W.-C. Lai, S. Netzel-Arnett, P. R. Mangan, J. A. Ardans, N. Caterina, W. G. Stetler-Stevenson, H. Birkedal-Hansen, and L. M. Wahl
Monocyte Membrane Type 1-Matrix Metalloproteinase. PROSTAGLANDIN-DEPENDENT REGULATION AND ROLE IN METALLOPROTEINASE-2 ACTIVATION
J. Biol. Chem., May 25, 2001; 276(22): 19027 - 19032.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1987 by the American Association for Cancer Research.